The maker of Ritz is recalling four carton sizes of cracker sandwiches after mislabeled packaging could pose a threat to people with nut allergies.

A popular ice cream brand has recalled one of its flavors due to a packaging error. DFA Dairy Brands, LLC issued a recall on 324 cartons of Friendly’s 48 fluid-ounce Cookies & Cream ice cream, according to a report shared Wednesday by the United States Food and Drug Administration (FDA). The recall was issued after it was discovered that the product was packaged in the Vanilla Bean flavor carton with a Cookies & Cream lid.

Counterfeit and substandard pharmaceuticals threaten the health of millions around the world. The World Health Organization (WHO) defines them as products that do not meet quality standards and specifications due to poor manufacturing or inadequate quality control. According to the agency, at least 1 in 10 medicines in low- and middle-income countries are substandard or falsified. As the WHO emphasizes the negative impact of counterfeit and substandard drugs on public health, relevant stakeholders must build clean and transparent pharmaceutical supply chains.  

RFID in Pharmaceuticals Market is anticipated to expand from $3.2 billion in 2024 to $9.8 billion by 2034, growing at a CAGR of approximately 11.8%. This rapid growth reflects the increasing adoption of Radio Frequency Identification (RFID) technology to enhance tracking, authentication, and management of pharmaceutical products.

From sourcing active pharmaceutical ingredients (APIs) and managing strict cold-chain protocols to navigating evolving regulatory landscapes, the sector faces mounting pressure from internal inefficiencies and external disruptions. Recent years have amplified these challenges, exposing vulnerabilities that threaten both operational continuity and patient outcomes.

New study identifies the pharmaceutical firms with the most drug recalls in the U.S. from 2012-2024. Aidapak Services leads with 538 total recalls, while King Bio Inc. tops the list for most hazardous Class I recalls with 465 dangerous violations. The data reveals significant fluctuations in pharmaceutical recall activity over the past 13 years. 2019 stands out as the worst year on record.

As the threat of counterfeiting continues to torment industry stakeholders and patients, more strategic approaches to serialization and traceability are forming.

In today’s fast-paced world, industries like pharma, food, and manufacturing face increasing pressure to maintain transparency, ensure compliance, and deliver products safely to customers. This is where a Track and Trace System comes in. From monitoring product journeys with barcode scanners to real-time insights through a GPS tracking system, businesses are adopting these solutions to improve efficiency, customer trust, and regulatory adherence. If you run a business in pharmaceutical packaging, food supply chains, or large-scale manufacturing, understanding the role of a track and trace system is no longer optional—it’s essential for growth and compliance.

At its essence, track and trace is a method of identifying, recording, and tracing the movement of a product at each point in the supply chain—from the sourcing of raw materials through manufacturing to distribution, retail, and ultimately, the end user.Imagine it like a virtual passport for every item. In contrast to legacy batch-level tracking, newer systems tend to take advantage of one-of-a-kind item-level serialization. This refers to the fact that each product—each pill bottle, each bottle of wine, each designer sweater—is assigned a unique, tamper-resistant identity.

The pharmaceutical industry is in a constant state of evolution, driven by technological advancements that are redefining everything from drug discovery to patient care. One of the most significant shifts is happening in a once-overlooked area: packaging. Far from being just a container, pharmaceutical packaging is now a critical component of the digital health ecosystem, offering unprecedented levels of safety, data, and efficiency.Smart packaging is at the forefront of this transformation. By integrating digital technologies into traditional packaging formats, companies are unlocking new capabilities that enhance product integrity, improve supply chain visibility, and strengthen regulatory compliance. This article explores the current innovations in smart packaging and examines the operational and strategic benefits for pharmaceutical companies.

Sustainability in retail is no longer a moral side-note it’s becoming a core expectation. From packaging and supply chains to customer communication, brands are under pressure to eliminate waste, increase transparency and create more responsible experiences. Yet many of the solutions that promise sustainability often demand expensive tools, new systems or major operational changes.

Otsuka ICU Medical LLC is issuing a voluntary recall to the user level, for a MISLABELLED lot of POTASSIUM CHLORIDE Inj. 20 mEq, NDC 0990-7077-14. The OVERWRAP label of lot 1030613, Expiration Date: 09-30-2026 may incorrectly identify the product as POTASSIUM CHLORIDE Inj. 10 mEq with NDC 0990-7074-26. Otsuka ICU Medical LLC has identified this discrepancy due to a manufacturing issue. The dosage is correctly printed on the labeling affixed to the product bag which is not visible when the 10 mEq OVERWRAP is in place. This notification details the issue and the required steps for you to perform.

In today’s fast-moving business world, transparency has become the foundation of trust between brands, retailers, and customers. Whether it’s food, pharma, or FMCG, people want to know where their products come from and how they reach them. That’s where QR track and trace comes into play, a technology that brings unmatched clarity, accountability, and efficiency across supply chains.

Pharmaceutical labeling is essential for safety, compliance and trust. From ensuring accurate dosage instructions to meeting strict global regulations, every detail matters. The best pharmaceutical label manufacturers combine advanced materials, cutting-edge printing technology and rigorous quality control to deliver labels that perform flawlessly under pressure.

We’ve all seen them: those ubiquitous pharmaceutical commercials featuring people frolicking through fields while a soothing voiceover lists an alarming array of potential side effects. According to recent survey data, these ads are doing their job—at least on paper. But a closer look reveals a significant gap between what people say they’ll do and what actually happens in the real world of healthcare decisions.

Unlike industries like beauty that maintain owned retail spaces for immersive brand experiences, packaging is often the only brand ambassador for grocery-bound products and their loyalty programmes are often reliant on retailers as well. Innovating in packaging designs can be a meaningful and low-cost brand activation for F&B players to encourage direct engagement.By viewing packaging as an opportunity for purposeful dialogue with consumers, companies can develop strategies that turn transactional moments into emotional bonds. Interactive technologies like QR codes and NFC chips offer a cost-effective loyalty solution, but most brands underutilise them by linking only to basic product information. The real opportunity lies in crafting unique post-scan experiences that deliver exclusive content, turning each scan into a branded moment that deepens relationships. In fact, consumers are likely to grow into brand ambassadors through positive technology experiences.

Experience how ZING Engagement Suite transforms offline touchpoints into compliant, omnichannel engagement with dynamic QR codes.✅ Instantly deliver pre-approved content✅ Enable demo requests and form submissions✅ Track real-time engagement✅ Stay compliant with audit-ready records💡 QR Code is a large part of ZING's omnichannel solution, empowering pharma teams to connect with HCPs anytime, anywhere—no app or login needed.

There is a reasonable probability that the inadvertent administration of penicillin G potassium injection, instead of intended cefazolin injection, may pose serious and potentially life-threatening adverse health consequences, including lack of efficacy leading to less than optimal treatment of severe infections, antibiotic resistance, adverse reactions, severe allergic reactions (e.g., anaphylaxis), drug interactions, cardiac arrhythmias resulting from high potassium especially in patients with kidney impairment, and delayed recovery.

From beauty to beverages, the most effective label designs do more than look good; they tell your brand’s story, reflect your industry, and stop the shelf-scroll in its tracks. Here's how to tailor labels for maximum impact by category.

As pressures on global supply chains increase, pharmaceutical, biotech, and medical device companies are recognizing that supply chain resiliency depends not only on internal strengths, but on the importance of external partnerships that are fully aligned with their goals and expectations. For companies evaluating a Contract Packaging Organization (CPO), it’s no longer enough to assess capacity or capabilities. Today, companies must rethink contract packaging and find partners that go beyond providing packaging services. Instead, they should seek partners that enhance manufacturing processes with flexibility, responsiveness, agility, and a deep commitment to quality. The greatest value is working with a CPO that serves as a strategic partner and extension of their team.